Skip to content

US · PRVA · MEDICAL - HEALTHCARE INFORMATION SERVICES

Privia Health Group, Inc. (PRVA) intrinsic value and stock valuation

$25.05as of 2026-11-21 · Mkt cap 3.02B

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Privia Health Group, Inc. DCF and intrinsic value

InvestorsCraft values PRVA with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from PRVA’s statements →

Privia Health Group, Inc. Graham Number

Graham Number: $5.23d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Healthcare Information Services Arlington, VA 22203 priviahealth.com

How the business is doing

Fiscal 2018–2025, USD

Revenue
$2.12B+21% 5y CAGRd
20182025
Net income
$22.9M-6% 5y CAGRd
20182025
Free cash flow
$162.2M+33.3% 5y CAGRd
20182025
Total equity
$790.9M+40.7% 5y CAGRd
20182025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2018–2025, USD
20252024202320222021
Revenue$2.12B$1.74B$1.66B$1.36B$966.2M
Operating income$34.2M$17M$20.7M-$-19.12M-$-217.44M
Net income$22.9M$14.4M$23.1M-$-8.59M-$-188.23M
EPSd$177.8K$114.5K$185.1K-$-77.6K-$-1.75M
Operating cash flow$163.4M$109.3M$80.8M$47.2M$55.1M
Capital expenditure-$-1.2M-$-5.02M-$-110K-$-100K-$-550K
Free cash flow$162.2M$104.3M$80.7M$47.1M$54.5M
Total assets$1.37B$1.14B$999.9M$792.8M$686.4M
Total debt$9.53M$5.59M$8.29M$11.5M$46.5M
Net debt-$-470.15M-$-485.56M-$-381.22M-$-336.49M-$-274.08M
Total equity$790.9M$683.5M$607.4M$519.1M$450.2M
Cash and short-term investments$479.7M$491.2M$389.5M$348M$320.6M
Income statement
20252024202320222021
Revenue$2.12B$1.74B$1.66B$1.36B$966.2M
Cost of revenue$1.91B$1.56B$1.5B$1.22B$902.6M
Gross profit$209.4M$176.9M$161.5M$134.8M$63.7M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$165.3M$152.6M$134.3M$149.3M$278.6M
Other expenses$9.91M$7.27M$6.53M$4.57M$2.46M
Operating expenses$175.2M$159.9M$140.9M$153.9M$281.1M
Cost and expenses$2.09B$1.72B$1.64B$1.38B$1.18B
Interest income$9.7M$10.9M$8.37M$540K$0.00
Interest expense$0.00$0.00$0.00$0.00$1.07M
Depreciation and amortization$9.91M$7.27M$6.53M$4.57M$2.46M
Ebitda$53.8M$35.1M$35.6M-$-14.01M-$-214.97M
Operating income$34.2M$17M$20.7M-$-19.12M-$-217.44M
Total other income/expenses, net$9.7M$10.9M$8.37M$540K-$-1.07M
Income before tax$43.9M$27.9M$29M-$-18.58M-$-218.51M
Income tax expense$14.2M$10.8M$7.99M-$-6.52M-$-27.86M
Net income$22.9M$14.4M$23.1M-$-8.59M-$-188.23M
Weighted average shares outstanding$122.2M$119.4M$116.7M$110.7M$107.8M
Weighted average diluted shares outstanding$128.9M$125.6M$124.7M$110.7M$107.8M
Balance sheet
20252024202320222021
Cash and short-term investments$479.7M$491.2M$389.5M$348M$320.6M
Net receivables$400.9M$316.2M$290.8M$189.6M$117.4M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$911M$834.8M$700.8M$552M$446.7M
Property, plant and equipment, net$9.3M$6.07M$8.94M$11.5M$14.1M
Goodwill and intangible assets$425.8M$251.4M$246.4M$184.3M$187.7M
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$458.4M$301M$299.1M$240.9M$239.7M
Total assets$1.37B$1.14B$999.9M$792.8M$686.4M
Accounts payable$7.97M$9.76M$7.88M$6.73M$2.97M
Short-term debt$2.2M$2.55M$3.04M$3.01M$3.77M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$568.5M$449.2M$387M$264.3M$190.5M
Long-term debt$7.33M$3.04M$5.25M$8.49M$42.7M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$9.91M$3.19M$5.56M$9.49M$45.7M
Capital lease obligations$9.53M$5.59M$8.29M$11.5M$13.9M
Total liabilities$578.4M$452.3M$392.5M$273.8M$236.2M
Common stock$1.24M$1.2M$1.18M$1.15M$1.08M
Retained earnings-$-156.31M-$-179.23M-$-193.61M-$-216.69M-$-208.11M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$790.9M$683.5M$607.4M$519.1M$450.2M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$9.53M$5.59M$8.29M$11.5M$46.5M
Net debt-$-470.15M-$-485.56M-$-381.22M-$-336.49M-$-274.08M
Cash flow statement
20252024202320222021
Net income$22.9M$14.4M$23.1M-$-12.06M-$-190.65M
Depreciation and amortization$9.91M$7.27M$6.53M$4.57M$2.46M
Stock-based compensation$0.00$0.00$0.00$67.4M$253.5M
Change in working capital$44.3M$19.5M$8.66M-$-6.35M$18M
Accounts receivable-$-36.67M-$-19.82M-$-96.88M-$-72.2M-$-14.64M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$14.8M$52.9M$118.4M$6.85M$0.00
Net cash provided by operating activities$163.4M$109.3M$80.8M$47.2M$55.1M
Investments in property, plant and equipment-$-1.2M-$-5.02M-$-110K-$-100K-$-550K
Acquisitions, net-$-181.72M-$-5.3M-$-47.89M$120K-$-32.23M
Net cash used for investing activities-$-181.57M-$-10.32M-$-48.01M-$-100K-$-32.77M
Common stock issued$8.05M$2.68M$8.74M$13.5M$223.7M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$6.7M$2.68M$8.74M-$-19.68M$213.7M
Net change in cash-$-11.46M$101.6M$41.5M$27.4M$235.9M
Cash at end of period$479.7M$491.2M$389.5M$348M$320.6M
Operating cash flow$163.4M$109.3M$80.8M$47.2M$55.1M
Capital expenditure-$-1.2M-$-5.02M-$-110K-$-100K-$-550K
Free cash flow$162.2M$104.3M$80.7M$47.1M$54.5M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Privia Health Group, Inc.

        Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that alleviates administrative tasks, freeing providers to focus on clinical care; a single-TIN medical group, which bolsters payer negotiations, facilitates clinical integration, and aligns financial incentives; an Accountable Care Organization (ACO) designed to engage patients, reduce inefficient utilization, and improve care coordination and patient quality metrics, thereby advancing value-based care; and a network connecting providers with new patient populations and enabling custom contracts with purchasers and payers. Founded in 2007, the company's headquarters are located in Arlington, Virginia. Privia Health Group, Inc. was formerly a subsidiary of Brighton Health Group Holdings, LLC.

        CEO
        Parth Mehrotra
        Employees
        1.23K
        Beta
        0.84

        Explore

        Frequently asked questions

        What is the intrinsic value of Privia Health Group, Inc. (PRVA)?

        Privia Health Group, Inc. (PRVA) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is PRVA undervalued?

        PRVA trades at a price of $25.05 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.